Target intelligence / Profile preview

Mitochondrial import inner membrane translocase subunit Tim17-A (TIMM17A)

Target
TIMM17A
Molecular classification
Transporter: member of protein translocases, Other: component of mitochondrial import machinery (TIM complex)[1][3][5][7]
01

Overview

Mitochondrial import inner membrane translocase subunit Tim17-A (TIMM17A) is a protein encoded by the human TIMM17A gene. It is an integral membrane protein of the inner mitochondrial membrane and is an essential component of the TIM23 complex that facilitates the translocation of nucleus-encoded and presequence-containing mitochondrial proteins from the cytosol into the mitochondrial matrix. TIMM17A forms the core of the TIM23 complex along with Tim23 and Tim21, creating a channel for protein translocation, and interacts with Tim44 and mitochondrial Hsp70 for further import and sorting[1][2][3][4][5]. TIMM17A is found in all eukaryotes and is highly conserved across species, underscoring its ancient and fundamental role in mitochondrial biogenesis and function. Mutations or dysfunction in this component would disrupt mitochondrial protein import and thereby compromise cellular energy metabolism, but there is no evidence currently linking TIMM17A to specific human disease phenotypes or identifying it as a direct druggable target[3][5][7].

Other names
Tim17-ATIMM17AMIMT17TIM17TIMM17Inner membrane preprotein translocase Tim17amitochondrial import inner membrane translocase subunit Tim17-Ainner membrane preprotein translocase Tim17amitochondrial inner membrane translocasepreprotein translocasetranslocase of inner mitochondrial membrane 17 homolog ATIMM17A[2][7]
02

Mechanism of action

None known. Not a primary drug target[7].

03

Biological functions

Protein import into mitochondrial matrixProtein transmembrane transporter activityIntegral to the TIM23 complex responsible for translocation of nuclear-encoded mitochondrial proteins across the mitochondrial inner membrane[1][2][3][4][5][7]
04

Disease associations

Other: No direct implication in common diseases or established therapeutic contexts (current literature does not link TIMM17A to major disease states such as cancer, neurodegeneration, inflammation, infection, or cardiovascular disease; may be indirectly involved in rare mitochondrial disorders or defects due to its essential mitochondrial role, but these are not specifically cited)[3][5][7]

Beyond the preview

Go deeper on Mitochondrial import inner membrane translocase subunit Tim17-A (TIMM17A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial import inner membrane translocase subunit Tim17-A (TIMM17A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call